Intestinal Colonization of IL-2 Deficient Mice with Non-Colitogenic B. vulgatus Prevents DC Maturation and T-Cell Polarization

Abstract

Background

IL-2 deficient (IL-2−/−) mice mono-colonized with E. coli mpk develop colitis whereas IL-2−/−-mice mono-colonized with B. vulgatus mpk do not and are even protected from E. coli mpk induced colitis.

Methodology/Principal Findings

We investigated if mono-colonization with E. coli mpk or B. vulgatus mpk differentially modulates distribution, activation and maturation of intestinal lamina propria (LP) dendritic cells (DC). LP DC in mice mono-colonized with protective B. vulgatus mpk or co-colonized with E. coli mpk/B. vulgatus mpk featured a semi-mature LP DC phenotype (CD40loCD80loMHC-IIhi) whereas mono-colonization with colitogenic E. coli mpk induced LP DC activation and maturation prior to onset of colitis. Accordingly, chemokine receptor (CCR) 7 surface expression was more strikingly enhanced in mesenteric lymph node DC from E. coli mpk than B. vulgatus mpk mono- or co-colonized mice. Mature but not semi-mature LP DC promoted Th1 polarization. As B. vulgatus mpk promotes differentiation of semi-mature DC presumably by IL-6, mRNA and protein expression of IL-6 was investigated in LP DC. The data demonstrated that IL-6 mRNA and protein was increased in LP DC of B. vulgatus mpk as compared to E. coli mpk mono-colonized IL-2−/−-mice. The B. vulgatus mpk mediated suppression of CCR7 expression and DC migration was abolished in IL-6−/−-DC in vitro.

Conclusions/Significance

From this data we conclude that the B. vulgatus triggered IL-6 secretion by LP DC in absence of proinflammatory cytokines such as IL-12 or TNF-α induces a semi-mature LP DC phenotype, which might prevent T-cell activation and thereby the induction of colitis in IL-2−/−-mice. The data provide new evidence that IL-6 might act as an immune regulatory cytokine in the mucosa by targeting intestinal DC.

About the Authors:

Martina Müller

Affiliation: Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany

Kerstin Fink

Affiliation: Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany

Julia Geisel

Affiliation: Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany

Frauke Kahl

Affiliation: Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany

Burghardt Jilge

Affiliation: University of Ulm, Ulm, Germany

Jörg Reimann

Affiliation: University of Ulm, Ulm, Germany

Nicolas Mach

Affiliation: Oncology Division, Geneva University Hospital, Geneva, Switzerland

Ingo B. Autenrieth

Affiliation: Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany

Julia S. Frick

* E-mail: [email protected]

Affiliation: Institute of Medical Microbiology and Hygiene, University of Tübingen, Tübingen, Germany

Introduction

The current pathophysiologic concept of inflammatory bowel diseases (IBD) proposes a multifactorial event with environmental, immunologic and genetic contributory factors [1], [2]. In some animal models environmental factors e.g. the intestinal microbiota, in addition to the genetic background have been identified as crucial factors for the development of IBD. Thus germfree (GF) and Bacteroides vulgatus mpk mono-colonized IL-2−/−-mice remain healthy whereas IL-2−/−-mice raised in a specific-pathogen-free (SPF) environment or when mono-colonized with E. coli mpk develop the disease [3]–[5]. DNA array experiments and cellular studies revealed that E. coli mpk is a non-pathogenic commensal E. coli strain [3].

DC are antigen presenting cells (APC) with important functions in the mucosal immune system. They have the capacity to stimulate naïve T-cells and thus are thought to be initiators of T-cell responses [6]. Intestinal DC transport microbial antigens to the mesenteric lymph nodes (MLN) and the spleen which causes the induction of systemic immune responses [7]. Activation and maturation of DC is induced by infectious agents and inflammatory products leading to increased expression of co-stimulatory and MHC-II molecules, cytokine production and T-cell activation [8]–[15]. In addition to bacterial stimuli, DC maturation is also regulated by cytokines [16].

Recent studies suggest a suppressive effect of IL-6 on DC activation and maturation [17]–[19]. Splenic DC isolated out of LPS treated IL-6−/−-mice showed an enhanced expression of CD86, suggesting that IL-6 may act as an immunosuppressive cytokine for DC differentiation [17]. Furthermore B. vulgatus-induced semi-mature DC were non-responsive upon restimulation with E. coli mpk in terms of DC maturation, T-cell priming and TNF-α production. This effect was abrogated by addition of anti-IL-6 monoclonal antibody (mAb) or mimicked with recombinant IL-6, suggesting that IL-6 induces semi-mature DC. This semi-mature DC were non-responsive to pro-inflammatory activation by E. coli mpk [18]. Recently, we described that N-palmitoyl-bis(palmitoyloxy)-propyl-cysteinylseryl-Lys4 (P3C)- or LPS-primed DC were non-responsive to P3C or LPS restimulation in terms of TNF-α production [20]. The mechanisms involved in tolerance were dependent on the concentration of the TLR ligand used for DC priming. Priming with LPS or P3C at high concentrations resulted in DC activation and maturation. In contrast, priming of DC with LPS or P3C at low concentrations resulted in an IL-6-dependent tolerance, which was abolished in IL-6 deficient DC, and was not accompanied by maturation of DC or by downregulation of TLR2 or TLR4 [20]. Together, these data provide evidence that IL-6 might play a bifunctional role in inflammatory diseases. Depending on the host status IL-6 may act as a pro-inflammatory or anti-inflammatory cytokine promoting or inhibiting T-cell priming and Th1 responses.

In this study we investigated whether and how intestinal colonization with E. coli mpk or B. vulgatus mpk differentially modulates activation, maturation and IL-6 production of intestinal lamina propria (LP) DC in IL-2−/−-mice prior to onset of colitis and whether differential modulation of LP DC might have an impact on induction or prevention of colitis in gnotobiotic IL-2−/−-mice in vivo.

Results

Characterization of LP DC in gnotobiotic IL-2−/−-mice

E. coli mpk induces colitis in IL-2−/−-mice, whereas the commensal strain B. vulgatus does not and even prevents E. coli mpk induced colitis [3]. In order to analyze the impact of commensal bacteria on the activation of intestinal inflammatory host reaction prior to onset of colitis we characterized the subsets of intestinal lamina propria (LP) DC, the expression of activation surface marker on LP DC and the host T-cell responses of gnotobiotic IL-2−/−-mice. Intestinal CD11c+CD19−CD3ε−DX5− LP DC from non-inflamed B. vulgatus mpk mono-colonized, non-inflamed E. coli mpk/B. vulgatus mpk co-colonized IL-2−/−-mice and non-inflamed E. coli mono-colonized IL-2−/−-mice prone to develop disease were prepared and analyzed by flow cytometry. LP DC from the inflamed intestine of SPF IL-2−/−-mice and healthy germfree IL-2−/−-mice served as reference. NK-, T- and B-cells were excluded from the analyses. The analysis of exclusively dendritic cells was ensured by analyzing only CD11chi positive, lineage negative cells to exclude CD11cint subsets of macrophages.

The expression of the DC activation marker CD40, CD80 and CD86 on intestinal LP DC was significantly enhanced in E. coli mpk mono-colonized mice and SPF mice as compared to B. vulgatus mpk mono-colonized, E. coli mpk/B. vulgatus mpk co-colonized and germfree mice (Figure 1; Figure S1). The phenotype (CD40loCD80loMHC-IIhi) of LP DC isolated from B. vulgatus mpk mono-colonized and from E. coli mpk/B. vulgatus mpk co-colonized mice matched the semi-mature DC phenotype previously described by us and others [18]–[20]. By contrast, the LP DC of E. coli mpk mono-colonized and SPF mice (CD40hiCD80hiMHC-IIhi) corresponded to an activated and mature DC phenotype (Figure 1; Figure S1).

[Figure omitted. See PDF.]

Figure 1. LP DC activation and maturation in germfree, gnotobiotic and SPF mice.

LP DC were isolated from the total intestine of GF, B. vulgatus mpk or E. coli mpk mono-colonized, E. coli mpk/B. vulgatus mpk co-colonized and SPF IL-2−/−-mice and analyzed for expression of CD40 and MHC-II by flow cytometry. The values represent at least six animals which were analyzed separately. Mean and SD were calculated from those independent experiments. Numbers indicate the percentage of positive cells±SD. Representative dotplots are shown from each group. * p<0.05 compared to germfree and B. vulgatus mpk mono-colonized IL-2−/−-mice.

https://doi.org/10.1371/journal.pone.0002376.g001

In germfree or B. vulgatus mpk mono- or E. coli mpk/B. vulgatus mpk co-colonized IL-2+/+-wild type (WT) mice the expression of activation and maturation markers on LP DC did not differ from LP DC isolated out of IL-2−/−-mice except for the expression of MHC class II which was slightly diminished in wild type mice. In E. coli mpk mono-colonized and SPF IL-2+/+-mice the expression of activation markers on LP DC was slightly enhanced as compared to germfree or B. vulgatus mpk mono- or E. coli mpk/B. vulgatus mpk co-colonized wild type mice, however the differences were not significant (Figure S2). Consistent with the mature and activated LP DC from E. coli mpk and SPF colonized IL-2−/−-mice we observed T-cells which were polarized in Th1 direction indicated by increased levels of IFN-γ. In addition, we detected a slight expression of IL-17 in LP T-cells isolated out of SPF IL-2−/−-mice (Figure 2). Unlike, in B. vulgatus mpk mono-colonized mice which do not develop colitis we observed neither IFN-γ or IL-17 nor IL-10 or IL-4 expression indicating that semi-mature LP DC did not lead to T-cell polarization (Figure 2).

[Figure omitted. See PDF.]

Figure 2. T-cell polarization in IL-2 −/−-mice prone to develop colitis and B. vulgatus mpk mono-colonized mice.

CD3+CD4+ LP T-cells of SPF and B. vulgatus mpk mono-colonized IL-2−/−-mice were prepared, intracellular cytokine staining for IFN-γ, IL-17, IL-4 and IL-10 was performed and the cytokine expression was analyzed by FACS. Numbers indicate the percentage of positive cells±SD. The results are representative for three independent experiments which were analyzed separately. Mean and SD were calculated from those independent experiments.

https://doi.org/10.1371/journal.pone.0002376.g002

We next addressed the question whether the colonization state has an impact on the composition of intestinal lamina propria DC subsets. For this purpose we analyzed the absolute number of LP DC and the percentage of myeloid (CD11c+CD11b+) and plasmacytoid (CD11c+B220+) LP DC in the different mouse groups. No differences in the percentage of LP DC subpopulations were observed comparing E. coli mpk or B. vulgatus mpk mono-colonized, co-colonized or germfree IL-2−/−-mice. Interestingly, in IL-2−/− SPF mice already suffering from colitis we observed an increase in plasmacytoid intestinal LP DC (Table 1).

[Figure omitted. See PDF.]

Table 1. Absolute number and percentage of total DC, myeloid and plasmacytoid DC.

https://doi.org/10.1371/journal.pone.0002376.t001

B. vulgatus mpk differentiates DC to a semi-mature phenotype

Recent studies have shown that IL-6 differentiates DC to a semi-mature phenotype (CD40loCD80loMHC-IIhi) which is characterized by a reduced responsiveness towards LPS amongst others [17]–[20]. In addition, the expression of chemokine receptor (CCR) 7 on DC was downregulated by IL-6 which resulted in reduced DC migration [19].

Herein we were able to show that mono-colonization of IL-2−/−-mice with B. vulgatus mpk differentiated intestinal LP DC to a semi-mature phenotype and was associated with absence of colitis. We next analyzed the modulation of CCR7 expression and DC migration by priming DC with the protective B. vulgatus mpk or the colitogenic E. coli mpk. Furthermore the impact of IL-6 on CCR7 expression and migration of DC was analyzed. WT and IL-6−/−-BMDC were stimulated with B. vulgatus mpk or E. coli mpk and CCR7 surface expression as well as CCR7 mRNA expression was determined. Priming WT BMDC with B. vulgatus mpk led to a significantly reduced CCR7 surface expression as compared to DC primed with E. coli mpk. In line with other studies, the B. vulgatus mpk primed semi-mature DC were less responsive towards subsequent LPS stimulation (Figure S3). In IL-6−/−-DC the inhibitory effect of B. vulgatus mpk regarding the CCR7 expression and the LPS responsiveness was abolished, indicating that B. vulgatus mpk suppresses CCR7 expression in an IL-6 dependent way (Figure 3A; Figure S3 and S4). Accordingly, in a transwell migration assay B. vulgatus mpk primed WT DC showed reduced migration towards the CCR7 ligands CCL19 and CCL21 as compared to E. coli mpk primed DC. The reduced migration of B. vulgatus mpk primed WT DC was abolished in IL-6−/−-DC. This indicates that the IL-6 dependent expression of CCR7 upon priming with B. vulgatus mpk leads to a reduced migration property of DC compared to E. coli mpk stimulated DC (Figure 3B). We next analyzed the CCR7 expression in vivo on intestinal lamina propria DC and DC isolated from mesenteric lymph nodes (MLN) of E. coli mpk or B. vulgatus mpk mono-colonized, E. coli/B. vulgatus co-colonized, SPF or germfree IL-2−/−-mice (Figure 4). No significant differences in the examined mouse groups were observed on LP DC (Figure 4). By contrast, DC isolated from the MLN of E. coli mpk mono-colonized mice showed a significantly increased expression of CCR7 as compared to B. vulgatus mpk mono-colonized mice, E. coli mpk/B. vulgatus mpk co-colonized or germfree mice. These data might indicate that LP DC of E. coli mpk mono-colonized mice are activated and migrate to the MLN while LP DC of B. vulgatus mpk mono-colonized mice develop a CD40loCCR7lo phenotype and seem to be less migratory.

[Figure omitted. See PDF.]

Figure 3. CCR7 expression by and migration of BMDC upon stimulation with B. vulgatus mpk or E. coli mpk.

Analysis of CCR7 surface expression in wild type or IL-6−/−-BMDC upon stimulation with B. vulgatus mpk or E. coli mpk (A). CCR7 surface expression was determined by FACS. One representative dotplot is shown out of three independent experiments. In vitro chemotaxis of B. vulgatus mpk or E. coli mpk stimulated wild type or IL-6−/−-BMDC towards CCL19 and CCL21 (B). 5×105 BMDC were stimulated with E. coli mpk or B. vulgatus mpk and migration was determined in a 4 h transwell chemotaxis assay. Number of migrated cells of mock controls and B. vulgatus mpk primed DC were normalized to the number of E. coli mpk stimulated cells migrated along the chemokine gradient to the lower compartment. The results are representative for three independent experiments. Each experiment was performed in triplicates, values represent mean±SD. * p<0.05 compared to mock control and B. vulgatus mpk stimulated DC. ** p<0.05 compared to mock control.

https://doi.org/10.1371/journal.pone.0002376.g003

[Figure omitted. See PDF.]

Figure 4. CCR7 expression on LP DC and MLN DC of germfree, gnotobiotic and SPF mice.

LP DC or MLN DC were isolated from the total intestine of GF, B. vulgatus mpk or E. coli mpk mono-colonized, E. coli mpk/B. vulgatus mpk co-colonized and SPF IL-2−/−-mice and analyzed for CCR7 expression. The results are representative for at least three animals which were analyzed separately. Mean and SD were calculated from those independent experiments. Numbers indicate the percentage of CCR7 positive cells±SD. * p<0.05 compared to B. vulgatus mpk mono-colonized, co-colonized and germfree mice.

https://doi.org/10.1371/journal.pone.0002376.g004

In line with these findings, the differential CCR7 expression on LP DC of E. coli mpk or B. vulgatus mpk mono-colonized mice resulted in different numbers of intestinal lamina propria DC. FACS analysis revealed significantly increased numbers of CD11c+ cells in the intestine of germfree, B. vulgatus mpk mono-colonized and E. coli mpk /B. vulgatus mpk co-colonized mice as compared to E. coli mpk mono-colonized and SPF mice (Table 1). We couldn't observe any differences in the location of CD11c+ cells in the lamina propria (Figure S5).

B. vulgatus mpk primed DC are one source of intestinal IL-6

Recently, we reported that mono-colonization of IL-2−/−-mice with protective B. vulgatus mpk leads to enhanced levels of intestinal IL-6 mRNA and decreased levels of TNF-α mRNA expression as compared to E. coli mpk mono-colonized IL-2−/−-mice [18]. This led to the notion that IL-6 in absence of TNF-α or IL-12 might play an immune-regulatory rather than an immune-activating role [18]. In order to determine whether the enhanced IL-6 level in the intestine of B. vulgatus mono-colonized mice originate from intestinal lamina propria DC, we determined the expression of IL-6 and TNF-α by intracellular FACS staining (Fig. 5A) and quantitative RT-PCR (Figure 5B).

[Figure omitted. See PDF.]

Figure 5. IL-6 and TNF-α expression in LP DC of E. coli mpk or B. vulgatus mpk mono-colonized mice.

LP DC were prepared, intracellular cytokine staining was performed and the cytokine expression was analyzed by FACS (A). For analysis of cytokine mRNA expression, LP DC were enriched by FACS sorting and expression of IL-6 and TNF-α mRNA was analyzed by quantitative RT-PCR (B). * p<0.05 compared to B. vulgatus mpk mono-colonized mice.

https://doi.org/10.1371/journal.pone.0002376.g005

The intracellular staining for IL-6 and TNF-α revealed an increased IL-6 cytokine expression in LP DC of B. vulgatus mpk as compared to E. coli mpk mono-colonized mice. In contrast, expression of TNF-α was significantly reduced in LP DC of B. vulgatus mpk mono-colonized mice (Figure 5A). In line with this, IL-6 mRNA levels were significantly enhanced in LP DC of B. vulgatus mpk as compared to E. coli mpk mono-colonized mice. TNF-α mRNA levels did not differ between LP DC of B. vulgatus mpk and E. coli mpk mono-colonized mice probably due to degradation of TNF-α mRNA after translation and might lead to the hypothesis that IL-6 mRNA is detectable over a longer period than TNF-α mRNA (Figure 5B).

Taken together our data indicate that B. vulgatus mpk might lead to differentiation of LP DC to a semi-mature phenotype, possibly by an IL-6 dependent mechanism. This mechanism might at least partially account for the prevention of colitis induction in IL-2−/−-mice and might indicate a new immune-regulatory role for IL-6.

Discussion

The exclusive presence of B. vulgatus mpk in the intestine of IL-2−/−-mice is generally well tolerated without signs of inflammation, whereas E. coli mpk elicits a pronounced inflammatory response [3]. We examined the effect of colonization on LP DC activation and maturation. Mono-colonization of IL-2−/−-mice with non-colitogenic B. vulgatus mpk induced a semi-mature LP DC phenotype (CD40loCD80loMHC-IIhi) [18], whereas mono-colonization with E. coli mpk resulted in activated and maturated DC (CD40hiCD80hiMHC-IIhi). In E. coli mpk mono-colonized and SPF IL-2+/+-mice no significant activation of LP DC was observed. The enhanced activation of LP DC in E. coli mpk mono-colonized and SPF IL-2−/−-mice might be the consequence of a defective intestinal homeostasis in IL-2−/−-mice prone to develop colitis.

In E. coli mpk but not B. vulgatus mpk mono-colonized IL-2−/−-mice we found, probably due to the E. coli mpk induced DC activation, a diminished number of LP DC in the intestine and an enhanced number of CCR7+ DC in the MLN. The enhanced expression of CCR7 and MHC-II expression in germfree IL-2−/−-mice indicates that even these mice lack intestinal microbiota, alimentary-antigens might lead to a slight activation of the mucosa-associated immune system. The absence of colitis in B. vulgatus mpk mono-colonized IL-2−/−-mice was associated with an enhanced production of IL-6 and a decreased production of TNF-α in LP DC as compared to E. coli mpk mono-colonized mice. Taken together these data suggest that B. vulgatus mpk induced IL-6 might account at least partially for the immune-regulatory function of B. vulgatus mpk and the prevention of colitis in B. vulgatus mpk mono-colonized IL-2−/−-mice.

Colitis development in SPF IL-2−/−-mice was characterized by a predominant Th1 response. However, we cannot exclude that an additional IL-17 response might also contribute to the intestinal inflammation. In presence of IL-6 and TGF-β T-cells differentiate into IL-17-producing Th17 cells [21], [22]. In previous studies we were able to detect intestinal expression of TGF-β and IL-6 mRNA in mice suffering from colitis [23]. This might be a possible explanation for the induction of an additional Th17 response. In line with previous studies [3], [18], the B. vulgatus mpk induced semi-mature DC phenotype, neither led to Th1 or Th17 nor to Th2 polarization. This is in line with recent studies showing that IL-6-STAT-3 mediated processes decreased the intracellular MHC-II αβ dimer, li (invariant chain) and H2-DM on DC and suppressed CD4+ T-cell mediated immune responses [24].

IL-6 mediates different responses of the host immune system. Anti-inflammatory as well as pro-inflammatory effects have been reported. Various studies showed that IL-6 plays an important role promoting Th2 polarization [25]. Furthermore, IL-6 upregulates the expression of suppressor of cytokine signaling (SOCS) 1 in T-cells which inhibits Th1 differentiation [26]. Hence, the presence of IL-6 may shift the Th1/Th2 balance towards Th2 [25]. On the other hand, IL-6 has been reported to act as a pro-inflammatory cytokine in several models of acute colitis. A neutralizing antibody against IL-6 receptor prevents colitis in TNBS colitis and in IL-10−/− mice [27] as well as in T-cell transfer colitis [28]. IL-6−/−-mice are reported to be less susceptible to DSS colitis [29].

In contrast, priming with B. vulgatus mpk ex vivo is known to induce semi-mature DC that show partial, IL-6-dependent resistance to a subsequent E. coli mpk stimulus [18]. The absence of colitis in B. vulgatus mpk mono-colonized IL-2−/− mice was associated with an increased expression of only IL-6 mRNA in the intestinal tissue [18]. Within the present study we were able to identify intestinal LP DC as one source of IL-6 in B. vulgatus mpk mono-colonized IL-2−/−-mice. Additionally, stimulation of DC with B. vulgatus mpk resulted in a decreased expression of CCR7 and led to a reduced migration of DC in vitro. This effect turned out to be IL-6 dependent, too. This is in line with recent studies reporting that DC pre-treated with IL-6 developed a semi-mature phenotype and downregulated CCR7 expression [19].

B. vulgatus mpk is phylogenetically closely related to Porphyromonas gingivalis. The LPS of P. gingivalis is less potential compared to enterobacterial LPS [30], [31]. Our group was able to show that the induction of semi-mature tolerogenic DC depended on the antigen concentration used for DC priming. Low antigen concentrations differentiated DC in dependency of IL-6 to tolerogenic DC that were non-responsive to subsequent TLR stimuli [20].

Which host pattern recognition receptors (PRR) mediate the interaction of luminal bacteria with the mucosa associated immune system is topic of ongoing discussions. Recently, it was shown that the induction of colitis in IL-2−/−-mice seems to be toll-like-receptor (TLR) independent, as IL-2−/− MyD88−/− TRIF−/− triple-deficient mice still developed colitis [32]. Whether in our model system TLRs or other PRRs have an impact on the IL-6 dependent modulation of DC by B. vulgatus mpk is topic of current experiments.

B. vulgatus mpk mono-colonized mice only showed expression of IL-6 mRNA [18], whereas E. coli mpk mono-colonized mice, prone to develop colitis and SPF IL-2−/−-mice already suffering from colitis, revealed high levels of IL-1α, IL-1β, TNF-α, IFN-γ, IL-10 and IL-6 mRNA in the intestine [3]. Therefore we hypothesize that under physiologic conditions IL-6 possibly contributes to maintenance of gut homeostasis, but in acute IBD with presence of pro-inflammatory cytokines IL-6 may act as a pro-inflammatory cytokine.

We found an increased CCR7 expression of MLN DC but not of LP DC in E. coli mpk mono-colonized mice prior to onset of colitis. This might be explained by the fact that upon activation DC upregulate CCR7 which confers responsiveness to CCL19 and CCL21 and migrate to secondary lymphoid organs [33], [34]. In B. vulgatus mpk mono-colonized and germfree mice, we found a low basic expression of CCR7 in both, LP DC and MLN DC indicating that there is constitutive trafficking of LP DC under steady-state conditions. This is in line with recent studies showing a constitutive trafficking of DC from the intestine to local lymph nodes in the absence of overt inflammation [35]. B. vulgatus mpk induced semi-mature IL-6 producing DC which showed only low constitutive trafficking, may differentiate adjacent LP DC to a semi-mature phenotype by a paracrine IL-6 loop. The local IL-6 cytokine milieu combined with the induction of semi-mature LP DC might inhibit T-cell activation and thereby inflammation as IL-6-STAT-3 mediated processes were shown to decrease the intracellular MHC-II αβ dimer, li (invariant chain) and H2-DM on DC and suppressed CD4+ T-cell mediated immune responses [24]. However, at present this hypothesis is highly speculative and further investigations have to elucidate the impact on B. vulgatus mpk primed IL-6 producing LP DC on the immune-homeostasis of the intestine.

In line with the increased CCR7 expression on MLN DC, E. coli mpk mono-colonized IL-2−/−-mice had a significantly diminished percentage of CD11c+ cells in the lamina propria as compared to B. vulgatus mpk mono-colonized mice. This might reflect the migration of mature LP DC of E. coli mpk mono-colonized mice to the MLN. The absolute LP DC number in SPF mice was enhanced, probably due to the severe inflammation in the intestine of these mice. Interestingly, we found an enhanced fraction of plasmacytoid DC (pDC) in SPF IL-2−/−-mice which already suffered from colitis as well as in E. coli mpk mono-colonized mice prone to develop colitis. Paradoxically, pDCs appear to have an intrinsic capacity to prime naive T-cells to differentiate into IL-10-producing Treg cells at a mature stage [36], [37]. Further studies have to evaluate whether this represents a counter regulation of the intestinal immune system which is not effective in IL-2−/−-mice as these animals lack Treg cells due to the IL-2 gene deficiency.

In summary, we conclude that mono-colonization of IL-2−/−-mice with B. vulgatus mpk drives LP DC to a semi-mature phenotype, characterized by reduced expression of DC activation markers and the DC homing factor CCR7. This protective effect of B. vulgatus mpk might be related to IL-6 secreted from B. vulgatus mpk primed LP DC. Therefore, our data provide new hints for an immune-regulating rather than immune-activating role of IL-6 in the colitis model of IL-2−/−-mice suggesting that IL-6 in the absence of TNF-α, IL-12 and IFN-γ exerts anti-inflammatory effects.

Materials and Methods

Animals and bacteria

Heterozygous mice from a mixed C57BL/6x129/Ola background were crossed to obtain IL-2−/− and wild type mice as described previously [3]. The mice were bred under gnotobiotic conditions at the University of Ulm, Germany. Gnotobiotic mice were maintained in a germfree environment or were mono-colonized with E. coli mpk [3] or B. vulgatus mpk [3]. The gnotobiotic state was controlled weekly and at the time of necropsy by culturing aerobic and anaerobic bacteria. At the age of 15 weeks mice were sacrificed. Animal experiments were reviewed and approved by an appropriate institutional review committee (Anzeige vom 01.05.06 Regierungspräsidium Tübingen).

Isolation of lamina propria and MLN leukocytes

For isolation of MLN leukocytes mesenteric lymph nodes were taken from IL-2 mice and extruded through a mesh, washed twice and collected for analysis by flow cytometry.

For isolation of LP leukocytes, the small and large intestine was removed, sliced and washed in PBS to remove fecal content. To remove the epithelium, the tissue was incubated by gentle shaking in separation medium containing 1 mM dithiothreitol (DTT) and 1 mM EDTA in Ca2+/Mg2+-free PBS supplemented with 1% FCS for 15 min. To eliminate residual epithelial cells the tissue was washed in PBS containing 1% FCS and then cut into small pieces, resuspended in digestion medium consisting RPMI 1640, 5% FCS, 0.5 mg/ml collagenase type VIII (Sigma) and 5 U/ml DNase (Roche) and incubated for 90 min at 37°C by gentle shaking. Cells were passed through a mesh, centrifuged and the pellet was resuspended in 40% Percoll and carefully overlaid onto 70% Percoll. The Percoll gradient was centrifuged for 20 min at 2000 rpm and the interface containing the lamina propria leukocytes was collected and washed in PBS with 1% FCS. The cell number was determined and the cells were subjected to flow cytometry analysis as described below [38].

Isolation of BMDC

Bone marrow cells were isolated and cultured as described by Lutz et al. [39] with minor modifications. Cells were harvested at day 8 and used to evaluate the effects of cellular challenge with E. coli mpk or B. vulgatus mpk on migration and CCR7 expression as described below.

Stimulation of BMDC with B. vulgatus mpk or E. coli mpk

Cells were stimulated at day 8 with viable bacteria MOI 10 at 37°C, 5% CO2. Gentamicin was added one hour after stimulation and cells were incubated for 4 h (mRNA expression analysis) or 20 h (flow cytometry analysis). After 20 h CFU of viable bacteria was determined to exclude bacterial overgrowth. Stimulation with PBS was used as mock control. To exclude effects of gentamicin the antibiotic was also added to the mock control.

Flow cytometry

BMDC were stimulated with B. vulgatus mpk or E. coli mpk as described above. 0.5 µg mAb/1×106 cells were incubated for 30 min at 4°C. 30 000 cells were analyzed by flow cytometry. LP DC were pre-incubated with the mAb 2.4G2 directed against the FcγRIII/II CD16/CD32 to block non-specific binding of antibodies to Fc-receptors. The following antibodies were used for staining: FITC conjugated anti-mouse CD40, clone 3/23 (rat IgG2a,κ), FITC conjugated anti-mouse CD3ε, clone 145-2C11 (Armenian Hamster IgG1, κ), FITC conjugated anti-mouse CD49b/Pan-NK cells, clone DX5 (rat IgM, κ), FITC conjugated anti-mouse CD19, clone 1D3 (rat IgG2a, κ), PE conjugated anti-mouse CD11c, clone HL3 (Armenian Hamster IgG1, λ), biotinylated anti-mouse CD80, clone 16-10A1 (Armenian Hamster IgG2, κ), biotinylated anti-mouse CD86, clone GL1 (rat IgG2a, κ), biotinylated anti-mouse I-Ab, clone AF6-120.1 (mouse IgG2a, κ), biotinylated anti-mouse CD40, clone 3/23, biotinylated anti-mouse CCR7, clone 4B12 (rat IgG2a), APC conjugated anti-mouse CD45R/B220, clone RA3-6B2 (rat IgG2a, κ) and APC conjugated anti-mouse CD11b, clone M1/70 (rat IgG2b, κ). SAv-PerCP and SAv-APC were used to detect binding of biotinylated antibodies.

Intracellular cytokine staining

LP T-cells from IL-2−/−-mice were isolated as described above and stimulated with paramethoxy-amphetamine (PMA, Sigma), Ionomycin (Sigma) and Monesin (BD Pharmingen) for 3 h and stained with FITC conjugated anti-mouse CD3ε, clone 145-2C11 (Armenian Hamster IgG1, κ) and APC conjugated anti-mouse CD4, clone RM4-5 (rat IgG2a, κ). As the absolute number of lamina propria DC isolated from the intestine of non-inflamed B. vulgatus mpk mono-colonized mice was too small to perform FACS sorting, RNA analysis and intracellular cytokine staining in DC, the IL-2−/−-mice received at the age of 13 weeks s.c. 1×106 B16-FL cells, a murine melanoma tumor cell line engineered to stably produce murine Flt3-L [40]. The mice were killed after 14 days. The expression of activation and maturation markers was unchanged as compared to untreated mice (Figure S6). Isolated LP leukocytes were stained with APC conjugated anti-mouse CD11c, clone HL3 (Armenian Hamster IgG1, λ2).

For intracellular staining cells were fixed and permeabilized with 150 µl BD Cytofix/Cytoperm™ for 20 min at 4°C. After washing twice with BD Perm/Wash™ cells were stained for 30 min at 4°C in 50 µl BD Perm/Wash™ (concentration: 0.5 µg mAb/1×106 cells). For T-cells PE conjugated anti-mouse IFN-γ, clone XMG1.2 (rat IgG1), PE conjugated anti-mouse TNF-α, clone MP6-XT22 (rat IgG1), PE conjugated anti-mouse IL-17, clone TC11-18H10.1 (rat IgG1, κ), PE conjugated anti-mouse IL-10, clone JES5-16E3 (rat IgG2a) and PE conjugated anti-mouse IL-4, clone 11B11 (rat IgG1) were used. DC were stained with PE conjugated anti-mouse IL-6, clone MP5-20F3 (rat IgG1) or with PE conjugated anti-mouse TNF-α, clone MP6-XT22 (rat IgG1). Afterwards, cells were washed twice with BD Perm/Wash™ and resuspended in PBS with 1% FCS prior to flow cytometric analysis.

CD11c+ cell sorting was performed by FACSAria. The collected cells were resuspended in RLT-Buffer for subsequent analysis of IL-6 and TNF-α mRNA expression.

Determination of CCR7 and IL-6 mRNA expression in BMDC or LP DC by quantitative real-time RT-PCR (qRT-PCR)

3×106 BMDC were stimulated with E. coli mpk or B. vulgatus mpk for 4 h as described above. LP DC were isolated from the intestine of E. coli mpk or B. vulgatus mpk mono-colonized IL-2−/−-mice, respectively. After stimulation or after FACS sorting of CD11c+ cells, RNA isolation was performed according to the manufacturer's instructions (Quiagen RNeasy Mini Kit 250). Extracted RNA was dissolved in water containing 0.1% diethyl-pyrocarbonate (DEPC). For reverse transcription 4 µg of RNA were mixed with 0.5 µg oligo (dT) 12-18 primer (Invitrogen Life Technologies) and DEPC water was added to a final volume of 10 µl, followed by incubation at 65°C for 10 min. After adding 10 µl of a solution containing 5× first strand buffer, 20 nmol/l DTT, 200 U Superscript II (Invitrogen Life Technologies), 40 U RNase Out (Invitrogen Life Technologies) and 2 mmol/l desoxynucleoside triphosphates (dNTPs) (Roth), the mixture was incubated at 37°C for 60 min. Finally the samples were heated at 90°C for 5 min, diluted with DEPC treated water, and stored at −20°C until further use.

qRT-PCR was carried out in duplicates in 96-well format on a GeneAmp 5700 Sequence Detection System (Applied Biosystems/Applera, Darmstadt, Germany). Each 20 µl reaction contained 10 µl TaqMan Universal PCR MasterMix (No AmpErase UNG, Applied Biosystems), 1 µl target gene specific Assay-on-Demand Gene Expression Assay Mix (Applied Biosystems), 4 µl PCR grade water and 5 µl cDNA. Thermal cycling conditions for all reactions were as follows: 2 min at 50°C, 10 min at 95°C, 40 cycles for 15 s at 95°C and 1 min at 60°C. The standard curve method was used for semiquantitative data analysis. Data were normalized by dividing the values of the target gene by the values of the housekeeping gene gapdh.

Cell migration assay

On day 9 BMDC stimulated with E. coli mpk or B. vulgatus mpk were resuspended in RPMI 1640, washed and 5×105 cells were added on the top of a transwell culture insert with 6.5 mm diameter and 3 µm pore size (BD Pharmingen). The chemokines CCL19 (100 ng/ml) and CCL21 (100 ng/ml) (both from Pepro Tech) were added to the lower compartment. CCL19 and CCL21 are the sole ligands for CCR7. The number of cells migrated to the lower chamber within 4 h was determined by flow cytometry.

Statistics

Statistical analyses were performed using ANOVA-One way followed by Dunnett's post test or the unpaired Student's t-test. P values<0.05 were considered significant. Error bars represent±SEM.

Supporting Information

[Figure omitted. See PDF.]

Figure S1.

LP DC activation and maturation in germfree, gnotobiotic and SPF IL-2−/−-mice: LP DC were isolated from the total intestine of GF, B. vulgatus or E. coli mono-colonized, E. coli/B. vulgatus co-colonized and SPF IL-2−/− mice and analyzed for expression of CD80 and CD86 by flow cytometry. The results are representative for at least three animals which were analyzed separately. Mean and SD were calculated from those independent experiments. Numbers indicate the percentage of positive cells±SD. * p<0.05 compared to germfree and B. vulgatus mono-colonized IL-2−/− mice.

https://doi.org/10.1371/journal.pone.0002376.s001

(1.14 MB TIF)

Figure S2.

LP DC were isolated from the total intestine of GF, B. vulgatus mpk or E. coli mpk mono-colonized, E. coli mpk/B. vulgatus mpk co-colonized and SPF IL-2+/+ WT mice and analyzed for expression of CD40, CD80, CD86 and MHC-II by flow cytometry. The results are representative for at least three animals which were analyzed separately. Mean and SD were calculated from those independent experiments. Numbers indicate the percentage of positive cells±SD. * p<0.05 compared to germfree and B. vulgatus mono-colonized IL-2−/− mice.

https://doi.org/10.1371/journal.pone.0002376.s002

(2.07 MB TIF)

Figure S3.

TNF-α and IL-6 production in wild type or IL-6−/− BMDC upon stimulation with B. vulgatus mpk or LPS or B. vulgatus and LPS. Secretion of TNF-α and IL-6 was determined by ELISA. Experiments were performed in duplicates, values represent means±SD of duplicates, results are representative for three independent experiments. * p<0.05 compared to LPS stimulated DC. ** p<0.05 compared to LPS and B. vulgatus mpk and LPS stimulated DC.

https://doi.org/10.1371/journal.pone.0002376.s003

(7.20 MB TIF)

Figure S4.

CCR7 mRNA levels were determined by qRT-PCR. Analysis of CCR7 mRNA expression was performed in duplicates, values represent means±SD of duplicates, results are representative for three independent experiments. ** p<0.05 compared to mock control.

https://doi.org/10.1371/journal.pone.0002376.s004

(0.52 MB TIF)

Figure S5.

Cryostat sections of distal ileum and colon of GF, B. vulgatus mpk or E. coli mpk mono-colonized or E. coli mpk/B. vulgatus mpk co-colonized IL-2−/−-mice, were incubated with fluorescence labeled anti-mouse CD11c mAb, nuclei were stained with DAPI. Scale bar represents 30 µm.

https://doi.org/10.1371/journal.pone.0002376.s005

(12.73 MB TIF)

Figure S6.

IL-2−/−-mice were treated s.c. with murine FLT-3L and sacrificed after 14 days. LP DC were isolated from the total intestine and analyzed for expression of CD40 and MHC-II by flow cytometry. The results are representative for at least three animals which were analyzed separately.

https://doi.org/10.1371/journal.pone.0002376.s006

(6.56 MB TIF)

Acknowledgments

The authors thank Sabine Schmidt, University of Ulm for expert gnotobiotic animal breeding facility.

Author Contributions

Conceived and designed the experiments: IA JF MM. Performed the experiments: JF MM KF JG FK. Analyzed the data: JF MM. Contributed reagents/materials/analysis tools: IA JF BJ JR NM. Wrote the paper: JF MM.

Citation: Müller M, Fink K, Geisel J, Kahl F, Jilge B, Reimann J, et al. (2008) Intestinal Colonization of IL-2 Deficient Mice with Non-Colitogenic B. vulgatus Prevents DC Maturation and T-Cell Polarization. PLoS ONE3(6): e2376. https://doi.org/10.1371/journal.pone.0002376

References

1. Fiocchi C (1998) Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 115: 182–205.C. Fiocchi1998Inflammatory bowel disease: etiology and pathogenesis.Gastroenterology115182205

2. MacDonald TT, Monteleone G, Pender SL (2000) Recent developments in the immunology of inflammatory bowel disease. Scand J Immunol 51: 2–9.TT MacDonaldG. MonteleoneSL Pender2000Recent developments in the immunology of inflammatory bowel disease.Scand J Immunol5129

3. Waidmann M, Bechtold O, Frick JS, Lehr HA, Schubert S, et al. (2003) Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice. Gastroenterology 125: 162–177.M. WaidmannO. BechtoldJS FrickHA LehrS. Schubert2003Bacteroides vulgatus protects against Escherichia coli-induced colitis in gnotobiotic interleukin-2-deficient mice.Gastroenterology125162177

4. Sadlack B, Merz H, Schorle H, Schimpl A, Feller AC, et al. (1993) Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene. Cell 75: 253–261.B. SadlackH. MerzH. SchorleA. SchimplAC Feller1993Ulcerative colitis-like disease in mice with a disrupted interleukin-2 gene.Cell75253261

5. Schultz M, Tonkonogy SL, Sellon RK, Veltkamp C, Godfrey VL, et al. (1999) IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation. Am J Physiol 276: G1461–G1472.M. SchultzSL TonkonogyRK SellonC. VeltkampVL Godfrey1999IL-2-deficient mice raised under germfree conditions develop delayed mild focal intestinal inflammation.Am J Physiol276G1461G1472

6. Cella M, Sallusto F, Lanzavecchia A (1997) Origin, maturation and antigen presenting function of dendritic cells. Curr Opin Immunol 9: 10–16.M. CellaF. SallustoA. Lanzavecchia1997Origin, maturation and antigen presenting function of dendritic cells.Curr Opin Immunol91016

7. Vazquez-Torres A, Jones-Carson J, Baumler AJ, Falkow S, Valdivia R, et al. (1999) Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes. Nature 401: 804–808.A. Vazquez-TorresJ. Jones-CarsonAJ BaumlerS. FalkowR. Valdivia1999Extraintestinal dissemination of Salmonella by CD18-expressing phagocytes.Nature401804808

8. Pulendran B, Palucka K, Banchereau J (2001) Sensing pathogens and tuning immune responses. Science 293: 253–256.B. PulendranK. PaluckaJ. Banchereau2001Sensing pathogens and tuning immune responses.Science293253256

9. Taguchi H, Takahashi M, Yamaguchi H, Osaki T, Komatsu A, et al. (2002) Experimental infection of germ-free mice with hyper-toxigenic enterohaemorrhagic Escherichia coli O157:H7, strain 6. J Med Microbiol 51: 336–343.H. TaguchiM. TakahashiH. YamaguchiT. OsakiA. Komatsu2002Experimental infection of germ-free mice with hyper-toxigenic enterohaemorrhagic Escherichia coli O157:H7, strain 6.J Med Microbiol51336343

10. Huang Q, Liu D, Majewski P, Schulte LC, Korn JM, et al. (2001) The plasticity of dendritic cell responses to pathogens and their components. Science 294: 870–875.Q. HuangD. LiuP. MajewskiLC SchulteJM Korn2001The plasticity of dendritic cell responses to pathogens and their components.Science294870875

11. Gagliardi MC, Sallusto F, Marinaro M, Langenkamp A, Lanzavecchia A, et al. (2000) Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming. Eur J Immunol 30: 2394–2403.MC GagliardiF. SallustoM. MarinaroA. LangenkampA. Lanzavecchia2000Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming.Eur J Immunol3023942403

12. de Jong EC, Vieira PL, Kalinski P, Schuitemaker JH, Tanaka Y, et al. (2002) Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals. J Immunol 168: 1704–1709.EC de JongPL VieiraP. KalinskiJH SchuitemakerY. Tanaka2002Microbial compounds selectively induce Th1 cell-promoting or Th2 cell-promoting dendritic cells in vitro with diverse th cell-polarizing signals.J Immunol16817041709

13. Banchereau J, Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392: 245–252.J. BanchereauRM Steinman1998Dendritic cells and the control of immunity.Nature392245252

14. Mahanty S, Hutchinson K, Agarwal S, McRae M, Rollin PE, et al. (2003) Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses. J Immunol 170: 2797–2801.S. MahantyK. HutchinsonS. AgarwalM. McRaePE Rollin2003Cutting edge: impairment of dendritic cells and adaptive immunity by Ebola and Lassa viruses.J Immunol17027972801

15. Lanzavecchia A, Sallusto F (2001) The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics. Curr Opin Immunol 13: 291–298.A. LanzavecchiaF. Sallusto2001The instructive role of dendritic cells on T cell responses: lineages, plasticity and kinetics.Curr Opin Immunol13291298

16. Reis e Sousa (2001) Dendritic cells as sensors of infection. Immunity 14: 495–498.Reis e Sousa2001Dendritic cells as sensors of infection.Immunity14495498

17. Park SJ, Nakagawa T, Kitamura H, Atsumi T, Kamon H, et al. (2004) IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation. J Immunol 173: 3844–3854.SJ ParkT. NakagawaH. KitamuraT. AtsumiH. Kamon2004IL-6 regulates in vivo dendritic cell differentiation through STAT3 activation.J Immunol17338443854

18. Frick JS, Zahir N, Muller M, Kahl F, Bechtold O, et al. (2006) Colitogenic and non-colitogenic commensal bacteria differentially trigger DC maturation and Th cell polarization: An important role for IL-6. Eur J Immunol 36: 1537–1547.JS FrickN. ZahirM. MullerF. KahlO. Bechtold2006Colitogenic and non-colitogenic commensal bacteria differentially trigger DC maturation and Th cell polarization: An important role for IL-6.Eur J Immunol3615371547

19. Hegde S, Pahne J, Smola-Hess S (2004) Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expression. FASEB J 18: 1439–1441.S. HegdeJ. PahneS. Smola-Hess2004Novel immunosuppressive properties of interleukin-6 in dendritic cells: inhibition of NF-kappaB binding activity and CCR7 expression.FASEB J1814391441

20. Geisel J, Kahl F, Muller M, Wagner H, Kirschning CJ, et al. (2007) IL-6 and Maturation Govern TLR2 and TLR4 Induced TLR Agonist Tolerance and Cross-Tolerance in Dendritic Cells. J Immunol 179: 5811–5818.J. GeiselF. KahlM. MullerH. WagnerCJ Kirschning2007IL-6 and Maturation Govern TLR2 and TLR4 Induced TLR Agonist Tolerance and Cross-Tolerance in Dendritic Cells.J Immunol17958115818

21. Veldhoen M, Hocking RJ, Flavell RA, Stockinger B (2006) Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat Immunol 7: 1151–1156.M. VeldhoenRJ HockingRA FlavellB. Stockinger2006Signals mediated by transforming growth factor-beta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease.Nat Immunol711511156

22. Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235–238.E. BettelliY. CarrierW. GaoT. KornTB Strom2006Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells.Nature441235238

23. Autenrieth IB, Bucheler N, Bohn E, Heinze G, Horak I (1997) Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation. Gut 41: 793–800.IB AutenriethN. BuchelerE. BohnG. HeinzeI. Horak1997Cytokine mRNA expression in intestinal tissue of interleukin-2 deficient mice with bowel inflammation.Gut41793800

24. Kitamura H, Kamon H, Sawa S, Park SJ, Katunuma N, et al. (2005) IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells. Immunity 23: 491–502.H. KitamuraH. KamonS. SawaSJ ParkN. Katunuma2005IL-6-STAT3 controls intracellular MHC class II alphabeta dimer level through cathepsin S activity in dendritic cells.Immunity23491502

25. Diehl S, Rincon M (2002) The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 39: 531–536.S. DiehlM. Rincon2002The two faces of IL-6 on Th1/Th2 differentiation.Mol Immunol39531536

26. Diehl S, Anguita J, Hoffmeyer A, Zapton T, Ihle JN, et al. (2000) Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1. Immunity 13: 805–815.S. DiehlJ. AnguitaA. HoffmeyerT. ZaptonJN Ihle2000Inhibition of Th1 differentiation by IL-6 is mediated by SOCS1.Immunity13805815

27. Atreya R, Mudter J, Finotto S, Mullberg J, Jostock T, et al. (2000) Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo. Nat Med 6: 583–588.R. AtreyaJ. MudterS. FinottoJ. MullbergT. Jostock2000Blockade of interleukin 6 trans signaling suppresses T-cell resistance against apoptosis in chronic intestinal inflammation: evidence in crohn disease and experimental colitis in vivo.Nat Med6583588

28. Yamamoto M, Yoshizaki K, Kishimoto T, Ito H (2000) IL-6 is required for the development of Th1 cell-mediated murine colitis. J Immunol 164: 4878–4882.M. YamamotoK. YoshizakiT. KishimotoH. Ito2000IL-6 is required for the development of Th1 cell-mediated murine colitis.J Immunol16448784882

29. Naito Y, Takagi T, Uchiyama K, Kuroda M, Kokura S, et al. (2004) Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice. Int J Mol Med 14: 191–196.Y. NaitoT. TakagiK. UchiyamaM. KurodaS. Kokura2004Reduced intestinal inflammation induced by dextran sodium sulfate in interleukin-6-deficient mice.Int J Mol Med14191196

30. Nair BC, Mayberry WR, Dziak R, Chen PB, Levine MJ, et al. (1983) Biological effects of a purified lipopolysaccharide from Bacteroides gingivalis. J Periodontal Res 18: 40–49.BC NairWR MayberryR. DziakPB ChenMJ Levine1983Biological effects of a purified lipopolysaccharide from Bacteroides gingivalis.J Periodontal Res184049

31. Mansheim BJ, Onderdonk AB, Kasper DL (1978) Immunochemical and biologic studies of the lipopolysaccharide of Bacteroides melaninogenicus subspecies asaccharolyticus. J Immunol 120: 72–78.BJ MansheimAB OnderdonkDL Kasper1978Immunochemical and biologic studies of the lipopolysaccharide of Bacteroides melaninogenicus subspecies asaccharolyticus.J Immunol1207278

32. Rakoff-Nahoum S, Hao L, Medzhitov R (2006) Role of toll-like receptors in spontaneous commensal-dependent colitis. Immunity 25: 319–329.S. Rakoff-NahoumL. HaoR. Medzhitov2006Role of toll-like receptors in spontaneous commensal-dependent colitis.Immunity25319329

33. Forster R, Schubel A, Breitfeld D, Kremmer E, Renner-Muller I, et al. (1999) CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs. Cell 99: 23–33.R. ForsterA. SchubelD. BreitfeldE. KremmerI. Renner-Muller1999CCR7 coordinates the primary immune response by establishing functional microenvironments in secondary lymphoid organs.Cell992333

34. Yanagihara S, Komura E, Nagafune J, Watarai H, Yamaguchi Y (1998) EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation. J Immunol 161: 3096–3102.S. YanagiharaE. KomuraJ. NagafuneH. WataraiY. Yamaguchi1998EBI1/CCR7 is a new member of dendritic cell chemokine receptor that is up-regulated upon maturation.J Immunol16130963102

35. Jang MH, Sougawa N, Tanaka T, Hirata T, Hiroi T, et al. (2006) CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes. J Immunol 176: 803–810.MH JangN. SougawaT. TanakaT. HirataT. Hiroi2006CCR7 is critically important for migration of dendritic cells in intestinal lamina propria to mesenteric lymph nodes.J Immunol176803810

36. Ito T, Yang M, Wang YH, Lande R, Gregorio J, et al. (2007) Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J Exp Med 204: 105–115.T. ItoM. YangYH WangR. LandeJ. Gregorio2007Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand.J Exp Med204105115

37. Moseman EA, Liang X, Dawson AJ, Panoskaltsis-Mortari A, Krieg AM, et al. (2004) Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells. J Immunol 173: 4433–4442.EA MosemanX. LiangAJ DawsonA. Panoskaltsis-MortariAM Krieg2004Human plasmacytoid dendritic cells activated by CpG oligodeoxynucleotides induce the generation of CD4+CD25+ regulatory T cells.J Immunol17344334442

38. Krajina T, Leithauser F, Reimann J (2004) MHC class II-independent CD25+ CD4+ CD8alpha beta+ alpha beta T cells attenuate CD4+ T cell-induced transfer colitis. Eur J Immunol 34: 705–714.T. KrajinaF. LeithauserJ. Reimann2004MHC class II-independent CD25+ CD4+ CD8alpha beta+ alpha beta T cells attenuate CD4+ T cell-induced transfer colitis.Eur J Immunol34705714

39. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, et al. (1999) An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods 223: 77–92.MB LutzN. KukutschAL OgilvieS. RossnerF. Koch1999An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow.J Immunol Methods2237792

40. Mach N, Gillessen S, Wilson SB, Sheehan C, Mihm M, et al. (2000) Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand. Cancer Res 60: 3239–3246.N. MachS. GillessenSB WilsonC. SheehanM. Mihm2000Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.Cancer Res6032393246